These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7770105)
1. Suppression of tumor growth in experimental 9L gliosarcoma model by copper depletion. Yoshida D; Ikeda Y; Nakazawa S Neurol Med Chir (Tokyo); 1995 Mar; 35(3):133-5. PubMed ID: 7770105 [TBL] [Abstract][Full Text] [Related]
2. Suppression of 9L gliosarcoma growth by copper depletion with copper-deficient diet and D-penicillamine. Yoshida D; Ikeda Y; Nakazawa S J Neurooncol; 1993 Aug; 17(2):91-7. PubMed ID: 8145063 [TBL] [Abstract][Full Text] [Related]
3. Copper chelation inhibits tumor angiogenesis in the experimental 9L gliosarcoma model. Yoshida D; Ikeda Y; Nakazawa S Neurosurgery; 1995 Aug; 37(2):287-92; discussion 292-3. PubMed ID: 7477781 [TBL] [Abstract][Full Text] [Related]
4. Anticopper treatment inhibits pseudopodial protrusion and the invasive spread of 9L gliosarcoma cells in the rat brain. Brem S; Tsanaclis AM; Zagzag D Neurosurgery; 1990 Mar; 26(3):391-6. PubMed ID: 2320207 [TBL] [Abstract][Full Text] [Related]
5. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy. Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448 [TBL] [Abstract][Full Text] [Related]
6. [Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma]. Miyagami M; Tazoe M; Kasahara E; Tsubokawa T Gan To Kagaku Ryoho; 1989 May; 16(5):2059-65. PubMed ID: 2499268 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor. Brem SS; Zagzag D; Tsanaclis AM; Gately S; Elkouby MP; Brien SE Am J Pathol; 1990 Nov; 137(5):1121-42. PubMed ID: 1700617 [TBL] [Abstract][Full Text] [Related]
8. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma. Morris GM; Micca PL; Coderre JA Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168 [TBL] [Abstract][Full Text] [Related]
9. Radiofrequency electromagnetic fields have no effect on the in vivo proliferation of the 9L brain tumor. Higashikubo R; Culbreth VO; Spitz DR; LaRegina MC; Pickard WF; Straube WL; Moros EG; Roti JL Radiat Res; 1999 Dec; 152(6):665-71. PubMed ID: 10581537 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of cisplatin efficacy by thalidomide in a 9L rat gliosarcoma model. Murphy S; Davey RA; Gu XQ; Haywood MC; McCann LA; Mather LE; Boyle FM J Neurooncol; 2007 Nov; 85(2):181-9. PubMed ID: 17534579 [TBL] [Abstract][Full Text] [Related]
11. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma. Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of glutamate transporter GLT-1 in peritumoral tissue associated with prolonged survival and decreases in tumor growth in a rat model of experimental malignant glioma. Sattler R; Tyler B; Hoover B; Coddington LT; Recinos V; Hwang L; Brem H; Rothstein JD J Neurosurg; 2013 Oct; 119(4):878-86. PubMed ID: 23909244 [TBL] [Abstract][Full Text] [Related]
13. Growth inhibition, tumor maturation, and extended survival in experimental brain tumors in rats treated with phenylacetate. Ram Z; Samid D; Walbridge S; Oshiro EM; Viola JJ; Tao-Cheng JH; Shack S; Thibault A; Myers CE; Oldfield EH Cancer Res; 1994 Jun; 54(11):2923-7. PubMed ID: 8187079 [TBL] [Abstract][Full Text] [Related]
14. Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation. Lewis JS; Sharp TL; Laforest R; Fujibayashi Y; Welch MJ J Nucl Med; 2001 Apr; 42(4):655-61. PubMed ID: 11337556 [TBL] [Abstract][Full Text] [Related]
17. A 9L gliosarcoma transplantation model for studying adoptive immunotherapy into the brains of conscious rats. Fleshner M; Watkins LR; Redd JM; Kruse CA; Bellgrau D Cell Transplant; 1992; 1(4):307-12. PubMed ID: 1344303 [TBL] [Abstract][Full Text] [Related]
18. Fractionated radiosurgery for 9L gliosarcoma in the rat brain. Kim JH; Khil MS; Kolozsvary A; Gutierrez JA; Brown SL Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1035-40. PubMed ID: 10571213 [TBL] [Abstract][Full Text] [Related]
19. The efficacy and distribution of suramin in the treatment of the 9L gliosarcoma. Olson JJ; Polk DM; Reisner A Neurosurgery; 1994 Feb; 34(2):297-308; discussion 308. PubMed ID: 8177391 [TBL] [Abstract][Full Text] [Related]
20. Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats. DiMeco F; Rhines LD; Hanes J; Tyler BM; Brat D; Torchiana E; Guarnieri M; Colombo MP; Pardoll DM; Finocchiaro G; Brem H; Olivi A J Neurosurg; 2000 Mar; 92(3):419-27. PubMed ID: 10701528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]